Detalhe da pesquisa
1.
Commercial insurance delays direct-acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients.
Transpl Infect Dis
; 23(1): e13449, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810315
2.
Transplantation of viral-positive hepatitis C-positive kidneys into uninfected recipients offers an opportunity to increase organ access.
Clin Transplant
; 34(4): e13833, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072689